Back to search

University of Ioannina

Φυσική ιστορία της αλκοολικής κίρρωσης στη Βορειοδυτική Ελλάδα: εμπειρία ενός κέντρου

Abstract

dc:description

Background: Alcohol-related cirrhosis exhibits an alarmingly increased prevalence and mortality and is currently the leading indication for liver transplantation worldwide. However, its clinical course has been poorly analyzed, particularly in relation to continued alcohol use after the diagnosis of cirrhosis. Objective: To comprehensively assess the liver-related outcomes of patients with compensated and decompensated alcohol-related cirrhosis focusing on the prognostic impact of post-diagnosis alcohol use. Methods: The present long-term retrospective study evaluated 440 patients with alcohol-related cirrhosis consecutively diagnosed at University hospital of Ioannina, which is the reference centre for northwestern Greece, between January 2000 and July 2017. All patients consumed alcohol until the diagnosis of cirrhosis defined as the inclusion date. We identified patients who abstained from alcohol defined as “abstinent ” and those who continue to consume any amount of alcohol after the diagnosis of cirrhosis defined “non-abstinent ”. Subsequently, we assessed the occurrence of liver-related clinical events, including decompensation, refractory ascites, hepatorenal syndrome, bacterial infections, hepatocellular carcinoma and death in relation to alcohol use and ascertained predictors of liver-related outcomes. Results: At baseline, 190 patients had compensated and 250 patients decompensated cirrhosis. Among patients with decompensated cirrhosis, 86.4% had ascites, 17.6% variceal bleeding, 9.2% hepatic encephalopathy while 12% had more than one decompensating events. During follow-up, 53.6% of patients remained abstinent.Among abstinents and non-abstinents, 53.3% and 60.7%, respectively, had decompensated cirrhosis at baseline. Higher Child-Pugh class was linked to increasedliver-related mortality. Further, non-abstinence was associated with significantly higher mortality across all Child-Pugh classes though the impact of alcohol use was attenuated in patients with more advanced cirrhosis. The probability of first decompensation among patients with compensated cirrhosis and next115decompensation among patients with decompensated cirrhosis was 55.6% and 56.5%at 5 years, respectively. Compared to abstinents, non-abstinents presented a greater5-year risk of first decompensation (80.2% vs. 36.8%;p<0.001) and nextdecompensation (87.9% vs. 20.6%;p<0.001), respectively. The 5-year risk of developing varices, ascites, variceal bleeding, and hepatic encephalopathy among patients with compensated cirrhosis was also significantly higher in non-abstinents compared to abstinents: 84.7% vs. 32%; p<0.001 (51.7% in total), 67.4% vs. 27.3%; p<0.001 (44.3% in total), 44.8% vs. 3.6%; p<0.001 (19.7% in total) and 46.3% vs. 15%; p<0.001 (27.4% in total), respectively. Ascites was by far the most common first-single decompensating event regardless of the continued use of alcohol yet non-abstinent patients who did not appear ascites showed a greater probability of developing variceal bleeding than hepatic encephalopathy. Regardless of the first event, the probability of development of all second-single events was significantly higher forpatients who continued alcohol use. Hepatic encephalopathy following ascites was the most likely sequence of events, particularly in non-abstinents. The non-abstinent patients with both ascites and hepatic encephalopathy carried also a further risk of developing variceal bleeding. On the other hand, among patients presenting variceal bleeding or hepatic encephalopathy as first single decompensating events, ascites was likely the only next event to occur. The probability of developing each decompensating event tended to be higher in patients with prior events rather in those with compensated cirrhosis. This was more evident for non-abstinents with variceal bleeding (42.5% vs. 27.8% at 5 years) and particularly for hepatic encephalopathy(19% vs. 2% at 1 year and 68.8% vs. 6.2%% at 5 years). In the latter regard, the probability of hepatic encephalopathy development any time during follow-up exceeded that as first decompensation event by 19% in total and by 35% in nonabstinents. Respective percentage increases were 3% and 6% for ascites and 6% and 16% for variceal bleeding. The 5-year probability of developing refractory ascites and hepatorenal syndrome was significantly higher in non-abstinents compared to abstinents: 25.6% vs. 4.2%; p=0.009 (12.9% in total) and 5.4% vs. 40.9%; p<0.001 (21.9% in total), respectively. Non-abstinents further carried a greater risk of developing spontaneous bacterial peritonitis, any bacterial infection, and hepatocellular carcinoma than abstinents at 5 years: 13.5% vs. 1.3%; p<0.001 (13.5% 116in total), 41.5% vs. 26.4%; p=0.01 (26.4% in total) and 18.7% vs. 6.2%; p=0.001 (11.9% in total). Among the entire cohort, patients with compensated and decompensated cirrhosis and those presenting ascites in first decompensation, the 5-year survival was significantly prolonged for abstinents vs. non-abstinents: 82.4% vs. 32.2%;p<0.001(57.2% in total), 90.7% vs. 45.9%;p<0.001 (70.8% in total), 73.8% vs. 22.9%;p<0.001(45.5% in total), and 67.4% vs. 27.3%;p<0.001 (39.8% in total), respectively. Nonabstinence had no effect on outcome of patients presenting variceal bleeding or hepatic encephalopathy in first decompensation. Long-term abstinence, ranging from 2 to 4 years, was required to influence decompensation and mortality. On multivariate Cox regression analysis, non-abstinence and higher Child-Pugh class independently predicted decompensation (hazard ratio [HR]:4.080, 95%CI:2.607-6.386; p<0.001 and HR:2.048, 95%CI:1.224-3.428; p=0.006, respectively), further decompensation (HR:5.276, 95%CI:3.085-9.023; p<0.01 and HR:9.240, 95%CI:3.678-23.218; p<0.001, respectively) and mortality in the entire cohort (HR:3.371, CI:2.388-4.882; p<0.001and HR:4.453, 95%CI:2.907-6.823; p<0.001, respectively) and in patients with compensated (HR:4.333, 95%CI:2.394-7.842; p<0.001 and HR:3.079, 95%CI:1.735-5.643; p<0.001, respectively) and decompensated cirrhosis (HR:3.243, 95%CI:2.023-5.198; p<0.001 and HR:6.026, 95%CI:2.897-12.532; p<0.001, respectively). Diabetes was also independent predictor of decompensation (HR:2.987, 95%CI:1.908-4.677; p<0.001) and further decompensation (HR:2.001, 95%CI: 1.318-3.038; p=0.001) while mortality was independently predicted by ascites in the entire cohort (HR:2.000, 95%CI:1.161-3.444; p=0.01) and age in patients with decompensated cirrhosis (HR:1.029, 95%CI:1.010-1.047; p=0.002). Conclusions: Alcohol-related cirrhosis present a high incidence of clinical events. The clinical course of compensated and decompensated alcohol-related cirrhosis is, however, dramatically accelerated in patients who continue to consume alcohol after the diagnosis of cirrhosis. Therefore, major interventions are urgently needed aimed to ensure abstinence and change prognosis of patients with alcohol-related cirrhosis.

Degree

thesis:*
Grantor dc:publisher
University of Ioannina
Year dc:date
2024

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Chouliara, Nikolleta
  • Χουλιάρα, Νικολλέτα

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/56809

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Chouliara, Nikolleta; Χουλιάρα, Νικολλέτα. Φυσική ιστορία της αλκοολικής κίρρωσης στη Βορειοδυτική Ελλάδα: εμπειρία ενός κέντρου. University of Ioannina, 2024. http://hdl.handle.net/10442/hedi/56809